Zobrazeno 1 - 10 of 295 pro vyhledávání: '"Frairia, C."'
1
Akademický článek
Arsenic trioxide neurotoxicity in acute promyelocytic leukemia patients: a single center experience.
Autor: Arrigo G; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Scaldaferri M; SC Pharmacy, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Audisio E; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Boscaro E; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Catania F; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Cattel F; SC Pharmacy, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Celona L; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Cerrano M; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Freilone R; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Giai V; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Urbino I; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., D'Ardia S; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Frairia C; SC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov 08, pp. 1-2. Date of Electronic Publication: 2024 Nov 08.
Zobrazit plný text záznamu
2
Akademický článek
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.
Autor: Crisà E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. elena.crisa@ircc.it.; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy. elena.crisa@ircc.it., Mora E; Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Germing U; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Bally C; Hématologie clinique, hôpital Necker. Assistance publique hôpitaux de Paris (APHP), Paris, France., Diez Campelo M; Hematology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain., Myllymäki M; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jädersten M; Department of Hematology M64 Karolinska University Hospital, Stockholm, Sweden., Komrokji R; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA., Platzbecker U; Department of Hematology, Cellular Therapy,Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Heidelberg, Germany., Al Ali NH; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA., Barraco D; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Dipartimento di Ematologia - ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Bargay JJ; Hematology Department. Hospital Son Llatzer, Mallorca, Spain., Bernal T; Hematology Department. Hospital Central de Asturias, Oviedo, Spain., López Cadenas F; Hematology Department. Hospital Clinico Universitario de Salamanca, Salamanca, Spain., Calvisi A; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; UOC Ematologia CTMO, Osp San Francesco Nuoro, Nuoro, Italy., Capodanno I; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; SOC Ematologia Azienda USL-IRCSS di Reggio Emilia, Reggio Emilia, Italy., Cerrano M; Hematology-University Hospital Città della Salute e della Scienza, Turin, Italy.; Hematology- Hospital Città della Salute e della Scienza, Turin, Italy., Ciancia R; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS Centro di Riferimento Oncologico (CRO) di Aviano (Pordenone), Aviano, Italy., Crugnola M; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology Unit and BMT center University Hospital of Parma, Parma, Italy., Kündgen A; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Finelli C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology 'Seràgnoli', Bologna, Italy., Fozza C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy., Frairia C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology- Hospital Città della Salute e della Scienza, Turin, Italy., Freja E; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland., Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Kubasch AS; Department of Hematology, Cellular Therapy,Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany., Jimenez MJ; Hematology Department. Hospital Gemans Trias i Pujol, Badalona, Spain., Latagliata R; Unità Operativa Complessa (UOC) Ematologia, Ospedale Belcolle, Viterbo and Division of Cellular Biotechnology and Hematology, Sapienza University, Rome, Italy., Hernandez Mohedo F; Hematology Department. Hopital Unversitario Virgen de las Nieves, Granada, Spain., Molero A; Hematology Department. Hospital Universitario Vall D'Hebron, Barcelona, Spain., Vara Pampliega M; Hematology Department. Hospital de Cruces, Barakaldo, Spain., Perez CA; Hematology Department. Hospital Universitario Reina Sofia, Cordoba, Spain., Pietrantuono G; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS CROB, Referral Cancer Center of Basilicata, Rionero In Vulture, Italy., Poloni A; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology, Università Politecnica Marche - AOU Marche, Ancona, Italy., Pomares H; Hematology Department. ICO Duran i Reynals, L'Hospitalet de LLobregat, LLobregat, Spain., Recasens V; Valle Recasens. Hematology Department. Hospital Miguel Servent, Zaragoza, Spain., Rüfer A; Division of Hematology, Luzerner Kantonsspital-in association with University Luzern, Luzern, Switzerland., Signori A; Department of Health Sciences - Section of Biostatistics University of Genoa, Genova, Italy., Hellstrom-Lindberg E; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Sanz G; Hematology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain.; CIBERONC, ISCIII, Madrid, Spain., Santini V; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy. valeria.santini@unifi.it.; MDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, Florence, Italy. valeria.santini@unifi.it.
Publikováno v: Leukemia [Leukemia] 2024 Oct; Vol. 38 (10), pp. 2259-2265. Date of Electronic Publication: 2024 Aug 05.
Zobrazit plný text záznamu
3
Editorial & Opinion
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Autor: Apolito V; Division of Haematology, University of Turin, Turin, Italy.; Pediatric Oncohematology, Stem Cell Transplantation and Cell Therapy Division, Regina Margherita Children's Hospital, Turin, Italy., Arrigo G; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Vasseur L; Hôpital Saint-Louis, Assistance, Publique-Hôpitaux de Paris, Paris, France., Olivi M; Division of Haematology, University of Turin, Turin, Italy., Perrone S; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Giai V; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Secreto C; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Di Biase F; Division of Haematology, University of Turin, Turin, Italy., De Simone MC; Division of Haematology, AORN Cardarelli, Naples, Italy., Copia C; Division of Haematology, AORN Cardarelli, Naples, Italy., Gravetti A; Division of Haematology, AORN Cardarelli, Naples, Italy., Freilone R; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Bruno B; Division of Haematology, University of Turin, Turin, Italy., Lanzarone G; Division of Haematology, University of Turin, Turin, Italy., Beggiato E; Division of Haematology, University of Turin, Turin, Italy., Frairia C; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Audisio E; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., D'Ardia S; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Ferrero D; Division of Haematology, University of Turin, Turin, Italy., Cerrano M; Division of Haematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Ferrara F; Division of Haematology, AORN Cardarelli, Naples, Italy.
Publikováno v: British journal of haematology [Br J Haematol] 2023 Nov; Vol. 203 (4), pp. e98-e101. Date of Electronic Publication: 2023 Aug 02.
Zobrazit plný text záznamu
4
Akademický článek
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience.
Autor: Urbino I; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Secreto C; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Apolito V; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy; Pediatric Oncohematology, Stem Cell Transplantation and Cell Therapy Division, Regina Margherita Children's Hospital, Turin, Italy., Olivi M; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy., Arrigo G; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy., Boscaro E; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy., Catania FM; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy., D'Ardia S; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Frairia C; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Giai V; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Freilone R; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Bruno B; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy; Division of Hematology, Allogeneic Transplant and Cell Therapy Unit, AOU 'Città della Salute e della Scienza di Torino' University of Turin, Italy., Lanzarone G; Division of Hematology, Allogeneic Transplant and Cell Therapy Unit, AOU 'Città della Salute e della Scienza di Torino' University of Turin, Italy., Giaccone L; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy; Division of Hematology, Allogeneic Transplant and Cell Therapy Unit, AOU 'Città della Salute e della Scienza di Torino' University of Turin, Italy., Busca A; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Dellacasa CM; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Ferrero D; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Italy; Division of Hematology, Allogeneic Transplant and Cell Therapy Unit, AOU 'Città della Salute e della Scienza di Torino' University of Turin, Italy., Audisio E; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy., Cerrano M; Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza, Turin, Italy. Electronic address: cerranomarco@gmail.com.
Publikováno v: Leukemia research [Leuk Res] 2024 Jan; Vol. 136, pp. 107421. Date of Electronic Publication: 2023 Nov 18.
Zobrazit plný text záznamu
5
Akademický článek
Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA.
Autor: Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy., Al Essa W; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Platzbecker U; Clinic and Policlinic of Hematology and Cellular Therapy, Oncology and Hemostaseology, University Hospital Leipzig, Germany., Niscola P; Hematology Unit, Sant'Eugenio Hospital, Rome, Italy., Palumbo GA; Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia,' University of Catania, Italy., Caocci G; Department of Medical Sciences and Public Health, University of Cagliari, Italy., Cottone F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Italy., Luppi M; University of Modena and Reggio Emilia, AOU Modena, Italy., Stauder R; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria., Ricco A; Hematology and Transplants Unit, University of Bari, Italy., Petranovic D; Department of Hematology, Clinical Hospital Center Rijeka, Croatia., Baron F; Department of Hematology, CHU de Liège, University of Liege, Belgium., Voso MT; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Italy., Fianchi L; Dipartimento Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy., Frairia C; Department of Oncology, Division of Hematology, AOU Città della Salute e della Scienza, Turin, Italy., Capodanno I; Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Sarlo C; Hematology and Stem Cell Transplantation Unit, University Campus Bio-Medico, Rome, Italy., Fedele M; Hematology, Ospedale San Gerardo, Monza, Italy., Lemoli RM; Cattedra di ematologia, Dipartimento di Medicina Interna (DiMI), Università di Genova, Italy.; Clinica Ematologica, IRCCS Policlinico San Martino, Genova, Italy., Invernizzi R; Department of Internal Medicine, San Matteo IRCCS Policlinic Foundation, University of Pavia, Italy., Vallisa D; Ematologia, Ospedale di Piacenza, Italy., Di Renzo N; Hematology and Stem Cell Transplant Unit, 'Vito Fazzi' Hospital, Lecce, Italy., Fozza C; Department of Medicine, Surgery, and Pharmacy, University of Sassari, Italy., Doro M; Unidade de Hematologia, Hemoterapia e Oncologia (UHHO), Serviço de Transplante de Medula Óssea (STMO), Complexo Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, Brazil., Giesinger JM; University Hospital of Psychiatry II, Medical University of Innsbruck, Austria., Vignetti M; Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy.
Publikováno v: HemaSphere [Hemasphere] 2023 Aug 30; Vol. 7 (9), pp. e944. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors.
Autor: Boscaro E; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Urbino I; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Catania FM; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Arrigo G; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Secreto C; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Olivi M; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., D'Ardia S; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Frairia C; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Giai V; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Freilone R; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Ferrero D; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Turin, Italy., Audisio E; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy., Cerrano M; Division of Hematology, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Publikováno v: Cancers [Cancers (Basel)] 2023 Jul 06; Vol. 15 (13). Date of Electronic Publication: 2023 Jul 06.
Zobrazit plný text záznamu
7
Akademický článek
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy.
Autor: Frairia C; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Nicolino B; Unit of Hematology, ASL TO4, Ivrea, Turin, Italy., Secreto C; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Messa E; Unit of Internal Medicine, ASL TO4, Chivasso, Turin, Italy., Arrigo G; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Busca A; Department of Oncology, SSD Trapianto Allogenico, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Cerrano M; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., D'Ardìa S; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Dellacasa C; Department of Oncology, SSD Trapianto Allogenico, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Evangelista A; Unit of Clinical Epidemiology, University-Hospital Città della Salute e della Scienza, Turin, Italy.; CPO, Piemonte, Turin, Italy., Freilone R; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Giai V; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Priolo G; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Urbino I; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy., Audisio E; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy.
Publikováno v: European journal of haematology [Eur J Haematol] 2023 Jun; Vol. 110 (6), pp. 696-705. Date of Electronic Publication: 2023 Mar 24.
Zobrazit plný text záznamu
8
Akademický článek
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study.
Autor: Urbino I; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., Frairia C; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., Busca A; Department of Oncology, SSCVD Trapianto di Cellule Staminali, Città della Salute e della Scienza, Turin, Italy., Corcione S; Department of Medical Sciences, Unit of Infectious Diseases, University of Turin, Turin, Italy.; Tufts University School of Medicine, Boston, MA, USA., D'Ardia S; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., Dellacasa CM; Department of Oncology, SSCVD Trapianto di Cellule Staminali, Città della Salute e della Scienza, Turin, Italy., Giai V; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., Secreto C; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., Freilone R; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., De Rosa FG; Department of Medical Sciences, Unit of Infectious Diseases, University of Turin, Turin, Italy., Aydin S; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy.; Department of Oncology, Hematology, Immuno-oncology and Rheumatology, University Hospital of Bonn, Bonn, Germany., Ciccone G; Unit of Clinical Epidemiology, CPO, Città della Salute e della Scienza, Turin, Italy., Rosato R; Unit of Clinical Epidemiology, CPO, Città della Salute e della Scienza, Turin, Italy., Cerrano M; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy., Audisio E; Department of Oncology, Division of Hematology, Città della Salute e della Scienza, Turin, Italy.
Publikováno v: Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2023 Mar 01; Vol. 15 (1), pp. e2023022. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje